These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7786943)

  • 1. Cervical screening in general practice.
    Pritchard DA; Straton JA; Hyndman J
    Aust J Public Health; 1995 Apr; 19(2):167-72. PubMed ID: 7786943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of interventions to promote cervical screening in general practice.
    Hyndman JC; Straton JA; Pritchard DA; Le Sueur H
    Aust N Z J Public Health; 1996 Jun; 20(3):272-7. PubMed ID: 8768417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How reminders given to patients and physicians affected pap smear use in a health maintenance organization: results of a randomized controlled trial.
    Burack RC; Gimotty PA; George J; McBride S; Moncrease A; Simon MS; Dews P; Coombs J
    Cancer; 1998 Jun; 82(12):2391-400. PubMed ID: 9635532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pap smear screening at an urban aboriginal health service: report of a practice audit and an evaluation of recruitment strategies.
    Hunt JM; Gless GL; Straton JA
    Aust N Z J Public Health; 1998 Oct; 22(6):720-5. PubMed ID: 9848971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effective analysis of recall methods for cervical cancer screening in Selangor--results from a prospective randomized controlled trial.
    Rashid RM; Ramli S; John J; Dahlui M
    Asian Pac J Cancer Prev; 2014; 15(13):5143-7. PubMed ID: 25040965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland.
    Virtanen A; Anttila A; Luostarinen T; Nieminen P
    Int J Cancer; 2011 Jun; 128(11):2681-7. PubMed ID: 20669228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cost-Effectiveness Analysis of Cervical Cancer Screening Using a Systematic Invitation System in Lithuania.
    Paulauskiene J; Stelemekas M; Ivanauskiene R; Petkeviciene J
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31835649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
    Abdul Rashid RM; Dahlui M
    Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can an appointment-letter intervention increase pap smear screening in Samliem, Khon Kaen, Thailand?
    Chumworathayi B; Yuenyao P; Luanratanakorn S; Pattamadilok J; Chalapati W; Na-Nhongkai C
    Asian Pac J Cancer Prev; 2007; 8(3):353-6. PubMed ID: 18159966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of invitation and reminder letters on cervical cancer screening participation rates in an organized screening program.
    Tavasoli SM; Pefoyo AJ; Hader J; Lee A; Kupets R
    Prev Med; 2016 Jul; 88():230-6. PubMed ID: 27143497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probability of early repeat Pap smear in an integrated cervical screening programme.
    Rosso A; Foglietta F; Naldoni C; Schincaglia P; Buzzi G; Camprincoli S; Serafini M; Busoli S; Leoni F; Grilli N; Bucchi L
    Eur J Cancer Prev; 2000 Aug; 9(4):269-74. PubMed ID: 10958330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomised controlled trial of methods of call and recall for cervical cytology screening.
    Pierce M; Lundy S; Palanisamy A; Winning S; King J
    BMJ; 1989 Jul; 299(6692):160-2. PubMed ID: 2504359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the phone call the most effective method for recall in cervical cancer screening?--results from a randomised control trial.
    Abdul Rashid RM; Mohamed M; Hamid ZA; Dahlui M
    Asian Pac J Cancer Prev; 2013; 14(10):5901-4. PubMed ID: 24289597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A team care model of cervical 
screening in a general practice.
    Rennie D; Boxsell J; Pedretti K
    Aust Fam Physician; 2015 Jul; 44(7):515-8. PubMed ID: 26590499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer.
    Eaker S; Adami HO; Granath F; Wilander E; Sparén P
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):346-54. PubMed ID: 15006907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of Screening Tools for Pap Smears in General Practice.
    Harding C; Seal A; Pilotto L; Mackey K; Duncan G; Huynh R; McWilliam R; Blake S
    J Innov Health Inform; 2016 Sep; 23(3):835. PubMed ID: 28059690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.